Home › Coronary Artery Disease › Mississippi › Tupelo
Coronary Artery Disease clinical trials in Tupelo, MS
4 studies for Coronary Artery Disease are looking for participants at sites in and around Tupelo (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Cardiology Associates of North Mississippi, Tupelo
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- - Nephrology and Hypertension Associates Ltd, Tupelo
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
Recruiting
- North Mississippi Medical Center, Tupelo
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Recruiting
- Cardiology Associates Research, LLC, Tupelo
- Cardiology Associates Research, LLC, Tupelo
About Coronary Artery Disease
Coronary artery disease (CAD) is the most common type of heart disease. It can lead to angina and heart attack. Read about symptoms and tests.
More about Coronary Artery Disease on MedlinePlus
Coronary Artery Disease trials in other cities
- New York City, NY21 studies
- Boston, MA16 studies
- Dallas, TX15 studies
- Atlanta, GA15 studies
- Jacksonville, FL14 studies
- Minneapolis, MN13 studies
- Cleveland, OH13 studies
- Nashville, TN11 studies
- Columbus, OH10 studies
- Durham, NC9 studies
- Philadelphia, PA8 studies
- Memphis, TN8 studies
Other studies in Tupelo
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.